NFE2L2 and thyroid cancer: Isodeoxyelephantopin (IDET) enhances paclitaxel sensitivity in thyroid cancer by promoting ROS‐mediated apoptosis through inhibition of the p62‐Keap1‐Nrf2 antioxidant pathway.